Abstract

Objective

The aims of the survey were to assess first experiences of Swiss COPD patients switching from the disposable to the new reusable Respimat inhaler, and to evaluate physicians´ and patients´ views of the new training material.

Methods

Patients with a confirmed diagnosis of COPD using a disposable Respimat inhaler for at least three months were included. Patients´ demographics, COPD stage, current treatment, and comorbidities relevant for the handling of the device were assessed. Further, patients were trained on the reusable Respimat by placebo inhaler, patient brochure, video cards/demo films and SMS reminder service. After at least one cartridge change, patients gave comprehensive feedback on their satisfaction with the reusable Respimat and physicians evaluated the need for re-training.

Results

235 patients participated in the survey. Of these, 37% suffered from comorbidities restricting the handling of the Respimat. 216 (92%) patients had a better overall satisfaction with the reusable than with the disposable Respimat. Dose counter (86%), monthly preparation (81%) and daily handling (77%) were also assessed as better by most of the patients. In 80% of cases, the user ability was stated as better than for the disposable Respimat. Less than 15% of the patients required further training. Placebo inhaler was the mostly preferred training material by both, physicians (in 86% of the patients) and patients (75%). In patients with comorbidities affecting inhaler handling, overall satisfaction was also better in 86% of the patients.

Conclusion

The majority of patients were satisfied with the new reusable Respimat device and proper handling could be attained using the provided training material, even in patients with restricting comorbidities.

中文翻译：

---

将 COPD 患者从一次性使用改为可重复使用的新型 Respimat 软雾吸入器：来自瑞士的真实世界研究

摘要

客观的

调查的目的是评估瑞士 COPD 患者从一次性吸入器转向新的可重复使用 Respimat 吸入器的初次体验，并评估医生和患者对新培训材料的看法。

方法

包括使用一次性 Respimat 吸入器至少三个月确诊为 COPD 的患者。评估了患者的人口统计学、COPD 分期、当前治疗和与设备操作相关的合并症。此外，通过安慰剂吸入器、患者手册、视频卡/演示影片和短信提醒服务，患者接受了可重复使用 Respimat 的培训。在至少更换一次滤芯后，患者对他们对可重复使用的 Respimat 的满意度给出了全面的反馈，并且医生评估了重新培训的必要性。

结果

235 名患者参与了调查。其中，37% 患有限制 Respimat 处理的合并症。216 (92%) 名患者对可重复使用的整体满意度高于一次性 Respimat。大多数患者也认为剂量计数器 (86%)、每月准备 (81%) 和日常处理 (77%) 更好。在 80% 的案例中，用户能力被认为比一次性 Respimat 更好。不到 15% 的患者需要进一步培训。安慰剂吸入器是医生（86% 的患者）和患者（75%）最喜欢的培训材料。在有影响吸入器操作的合并症的患者中，86% 的患者的总体满意度也更高。

结论

大多数患者对新的可重复使用的 Respimat 设备感到满意，并且可以使用提供的培训材料进行适当的操作，即使是患有限制性合并症的患者。